OxyContin advertiser to pay $350M in first-ever opioid marketing settlement

A French advertising company that worked on Purdue Pharma’s OxyContin account agreed to pay $350 million to settle a lawsuit accusing it of falsely marketing opioids as safe and unable to be abused.